These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 9373613)
41. [Methotrexate in rheumatology: a therapeutic revolution]. Kaye O; Ribbens C; Hauwaert C; Malaise MG Rev Med Liege; 1995 Nov; 50(11):453-7. PubMed ID: 8532990 [No Abstract] [Full Text] [Related]
42. Late-onset methotrexate-induced pneumonitis with neutrophilia in bronchoalveolar lavage fluid. Yamakawa H; Yoshida M; Takagi M; Kuwano K BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25267808 [TBL] [Abstract][Full Text] [Related]
43. Visceral leishmaniasis in a patient with rheumatoid arthritis treated with methotrexate. Loarce-Martos J; Garrote-Corral S; Gioia F; Bachiller-Corral J Reumatol Clin (Engl Ed); 2019; 15(6):e130-e132. PubMed ID: 28958842 [TBL] [Abstract][Full Text] [Related]
45. Methotrexate in rheumatoid arthritis: when NSAIDs fail. Flynn JA; Hellmann DB Cleve Clin J Med; 1995; 62(6):351-9. PubMed ID: 8556805 [TBL] [Abstract][Full Text] [Related]
46. Recommendations for the therapeutics of methotrexate in rheumatoid arthritis. Murphy G; Coughlan R; Devlin J; FitzGerald O; McCarthy G Ir Med J; 2009 Jun; 102(6):170-2. PubMed ID: 19722351 [No Abstract] [Full Text] [Related]
47. Fatal pulmonary lymphomatoid granulomatosis in a patient taking methotrexate for rheumatoid arthritis. Blanchart K; Paciencia M; Seguin A; Chantepie S; Du Cheyron D; Charbonneau P; Galateau-Salle F; Terzi N Minerva Anestesiol; 2014 Jan; 80(1):119-20. PubMed ID: 23857444 [No Abstract] [Full Text] [Related]
48. Accelerated cutaneous nodulosis during methotrexate therapy in a patient with rheumatoid arthritis. Williams FM; Cohen PR; Arnett FC J Am Acad Dermatol; 1998 Aug; 39(2 Pt 2):359-62. PubMed ID: 9703153 [TBL] [Abstract][Full Text] [Related]
49. Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update. Ling SF; Bluett J Pharmacogenomics; 2020 Jan; 21(1):3-6. PubMed ID: 31849277 [No Abstract] [Full Text] [Related]
50. A preliminary investigation of cognitive function in rheumatoid arthritis patients on long-term methotrexate treatment. Meade T; Cumming S; Hallab L; Spencer D; Howe G; Manolios N J Health Psychol; 2013 Oct; 18(10):1353-9. PubMed ID: 23188915 [TBL] [Abstract][Full Text] [Related]
51. Unexplained amenorrhea in a patient taking methotrexate for the treatment of rheumatoid arthritis. Kroft J; Sabra S; Arthur R; Wolfman W Gynecol Endocrinol; 2010 Mar; 26(3):179-80. PubMed ID: 19916871 [TBL] [Abstract][Full Text] [Related]
52. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 1. Methotrexate]. Suzuki Y; Chinen N Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2902-9. PubMed ID: 22175129 [No Abstract] [Full Text] [Related]
53. Folic and folinic acid supplementation reduces methotrexate gastrointestinal side effects in rheumatoid arthritis. Pincus T Clin Exp Rheumatol; 1998; 16(6):667-8. PubMed ID: 9844757 [No Abstract] [Full Text] [Related]
54. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis. Mroczkowski PJ; Weinblatt ME; Kremer JM Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S66-8. PubMed ID: 10589360 [TBL] [Abstract][Full Text] [Related]
55. Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference? Dervieux T J Rheumatol; 2008 Apr; 35(4):550-2. PubMed ID: 18398948 [No Abstract] [Full Text] [Related]